B Cell-Directed Therapeutics in Multiple Sclerosis: Rationale and Clinical Evidence
Crossref DOI link: https://doi.org/10.1007/s40263-016-0396-6
Published Online: 2016-11-14
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kinzel, Silke
Weber, Martin S.
Funding for this research was provided by:
NMSS (PP 1660)
Deutsche Forschungsgemeinschaft (WE 3547/4-1)
License valid from 2016-11-14